June 14, 2025
Boston, United States
BIO International Convention
Our CEO Marc Dechamps will be attending BIO this year. He will be connecting with fellow biotech innovators and potential pharmaceutical partners at this landmark industry event.
Events
- Newsroom
- /Events
-
![BIO International Convention]()
-
![European Stroke Organisation Conference 2025]()
May 21, 2025
Helsinki, Finland
European Stroke Organisation Conference 2025
Part of Bioxodes team will be attending the European Stroke Organisation Congress (ESOC) this year.
Read more -
![BioEquity Europe]()
May 12, 2025
Bruges, Belgium
BioEquity Europe
Our CEO Marc Dechamps will be presenting at the 25th edition of BioEquity Europe in Bruges
-
![LSX World Congress Europe]()
April 28, 2025
London, United Kingdom
LSX World Congress Europe
Our CEO Marc Dechamps will be presenting in front of investors at the LSX World Congress in London.
-
![BioEurope Spring 2025]()
March 17, 2025
Milan, Belgium
BioEurope Spring 2025
Our CEO Marc Dechamps will be meeting the health community in Milan on the premier European life science conference in Milan from March 17th - 19th. Reach out if you want to connect and get the latest updates on our advancements.
-
![International Stroke Conference 2025]()
February 05, 2025
Los Angeles, United States
International Stroke Conference 2025
Bioxodes will participate in the upcoming International Stroke Conference (ISC) 2025, taking place from February 5–7, 2025, at the Los Angeles Convention Center in Los Angeles, California. ISC is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease and brain health. Valérie Pireaux, Preclinical Scientist at Bioxodes, will present the latest preclinical data on BIOX-101 in intracerebral hemorrhage. This presentation highlights our commitment to advancing innovative solutions in stroke care.
Read more -
![Brain Innovation Days]()
November 13, 2024
Brussels, Belgium
Brain Innovation Days
Bioxodes will participate in the Brain Innovation Days on November 13th and 14th, with our CEO, Marc Dechamps, and CMO, Hans Warrinnier, attending in person. Our CMO will present a poster titled "A Tick Saliva Molecule to Rescue Lives After Intracerebral Haemorrhage."
Read more -
![BioEurope Fall 2023]()
November 06, 2023
Munich, Germany
BioEurope Fall 2023
Bioxodes will be part of BioEurope Fall, our CEO Marc Dechamps will be on site for partnering meetings.
-
![HealthTech Innovation Days #5]()
October 24, 2023
Paris, France
HealthTech Innovation Days #5
Bioxodes will be present at the 5th Edition of the HealthTech Innovation Days
-
![23rd Annual Biotech in Europe Forum - Sachs Associates]()
September 20, 2023
Basel, Switzerland
23rd Annual Biotech in Europe Forum - Sachs Associates
Bioxodes' CEO March Dechamps presents at the 23rd Annual Biotech in Europe Forum for Global Parntering & Investment, organised by Sachs Associates
Read more -
![ISTH 2023 Congress]()
June 26, 2023
Montréal, Canada
ISTH 2023 Congress
Bioxodes presented up-to-date preclinical data in intracerebral hemorrhage during the annual ISTH congress 2023 in Montréal.
Read more -
![ESOC 2023]()
May 24, 2023
Munich, Germany
ESOC 2023
Bioxodes presented the latest developments of its lead candidate Ir-CPI at ESOC 2023.
Read more -
![ESOTA 2023]()
May 23, 2023
Munich
ESOTA 2023
Bioxodes presented at the 12th ESOTA educational seminar that focused on: “Running international trials: different perspectives”.
Read more -
![Bio€quity Europe 2023]()
May 14, 2023
Dublin, Ireland
Bio€quity Europe 2023
Marc Dechamps, CEO of Bioxodes, will give a presentation as part of the ‘Autoimmune, Inflammation and Thrombosis’ track.
Read more -
![Biotech Showcase™ 2023]()
January 09, 2023
San Francisco, USA
Biotech Showcase™ 2023
Join Bioxodes at the Biotech Showcase™ 2023. Marc Dechamps, our CEO, will present a corporate overview on Tuesday, January 10, 2023, at 11:30 am PST.
Read more -
![HealthTech Innovation Days #4]()
October 13, 2022
Paris, France
HealthTech Innovation Days #4
Join Bioxodes at the HTID#4. We'll be happy to discuss about our lead product Ir-CPI and the new developments in intracerebral haemorrhage.
-
![BIO-Europe Fall 2019]()
November 11, 2019
Hamburg, Germany
BIO-Europe Fall 2019
Edmond Godfroid, CEO and Ludwig Camusot, business developer represented Bioxodes at BIO-Europe Fall 2019.
-
![ISTH 2019]()
July 07, 2019
Melbourne, Australia
ISTH 2019
Bioxodes presented up-to-date preclinical data during the annual ISTH congress on Sunday 7 July 2019 in Melbourne.
Read more -
![ISTH SSC 2018]()
July 19, 2018
Dublin, Ireland
ISTH SSC 2018
Bioxodes presented up-to-date preclinical data during the annual ISTH SSC meeting on Thursday 19 July 2018 in Dublin.
Read more -
![ISTH 2017]()
July 10, 2017
Berlin, Germany
ISTH 2017
Bioxodes presented preclinical data for its main product, Ir-CPI, at ISTH 2017 annual congress.
Read more -
![ISTH SSC 2016]()
May 25, 2016
Montpellier, France
ISTH SSC 2016
Bioxodes participated at the ISTH SSC 2016 annual congress.
-
![ISTH 2015]()
June 20, 2015
Toronto, Canada
ISTH 2015
Bioxodes presented preclinical data for its main product, Ir-CPI, at ISTH 2015 annual congress.
